Recently, immunohistochemistry (IHC) labeling of AXL in a series of more than 300 clear cell RCC (ccRCC) tissues revealed that high AXL expression is associated with increased expression of PD-L1 on carcinoma cells (188). Here, AXL is linked to nonpapillary renal cell carcinoma.